AgeX Therapeutics, Inc. (AGE)

SG&A Expenses

$11.60M

TTM · Period ending: · USD

AGE logo

AGE SG&A Expenses

Latest reported$11.60M
AGE TTM SG&A Expenses ($5.65M → $11.60M)
High-resolution chart · PNG

AGE sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

AgeX Therapeutics, Inc. SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
11,596,000
11,171,000
10,997,000
10,990,000
11,160,000
10,940,000
9,253,000
9,887,000
9,148,000
8,555,000
9,328,000
7,476,000
6,696,000
6,304,000
5,971,000
5,907,000
5,936,000
6,346,000
6,708,000
6,919,000
7,447,000
7,352,000
7,403,000
7,392,000
7,637,000
8,103,000
8,139,000
8,390,000
7,450,000
6,466,000
5,647,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.